drugset / Trial / NCT01367990
Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
Phase 1
Terminated
3 enrolled
ProCertus BioPharm, Inc
H. Lee Moffitt Cancer Center and Research Institute · collab
NaSingle-groupOpen-labelSupportive care
Summary
The study will evaluate the safety of topical norepinephrine in head and neck cancer patients who are receiving treatment with intensity modulated radiotherapy (IMRT). The study will also provide information about whether topical norepinephrine can prevent or decrease the severity of the radiation-induced alopecia experienced by these patients.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-02
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norepinephrine | Other / unclassified | 1.6 ml | Topical |